Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action
Annielle Mendes Brito da Silva1, Laíz Costa Silva-Gonçalves1, Fernando Augusto Oliveira2
1Laboratório de Neurobiologia Estrutural e Funcional (LaNEF), Departamento de Biofísica, Escola Paulista de Medicina, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil.
Abstract:
Glioblastoma multiforme is the most common and lethal malignant brain tumor. Because of its complexity and heterogeneity, this tumor has become resistant to conventional therapies and the available treatment produces multiple side effects. Here, using multiple experimental approaches, we demonstrate that three mastoparan peptides-Polybia-MP1, Mastoparan X, and HR1-from solitary wasp venom exhibit potent anticancer activity toward human glioblastoma multiforme cells. Importantly, the antiglioblastoma action of mastoparan peptides occurs by membranolytic activity, leading to necrosis. Our data also suggest a direct relation between mastoparan membranolytic potency and the presence of negatively charged phospholipids like phosphatidylserine. Collectively, these data may warrant additional studies for mastoparan peptides as new agents for the treatment of glioblastoma multiforme brain tumor.
Insights
Mastoparan peptides from wasp venom show potent anticancer effects against glioblastoma multiforme, a lethal brain tumor. These peptides work by destroying cancer cell membranes, offering a promising new avenue for glioblastoma treatment.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Glioblastoma multiforme is the most aggressive and fatal primary brain tumor.
- Tumor complexity and heterogeneity contribute to resistance against standard therapies.
- Current treatments for glioblastoma multiforme often result in significant side effects.
Purpose of the Study:
- To investigate the anticancer potential of specific mastoparan peptides against human glioblastoma multiforme cells.
- To elucidate the mechanism of action for mastoparan peptides in glioblastoma treatment.
Main Methods:
- Utilized multiple experimental approaches to assess peptide efficacy.
- Investigated the membranolytic activity of mastoparan peptides.
- Analyzed the correlation between peptide potency and phospholipid composition.
Main Results:
- Three mastoparan peptides (Polybia-MP1, Mastoparan X, HR1) demonstrated significant anticancer activity against glioblastoma cells.
- The anticancer effect was attributed to membranolysis, inducing necrotic cell death.
- Peptide membranolytic potency correlated with the presence of negatively charged phospholipids, such as phosphatidylserine.
Conclusions:
- Mastoparan peptides exhibit potent anti-glioblastoma activity through a membranolytic mechanism.
- The findings suggest mastoparan peptides as potential novel therapeutic agents for glioblastoma multiforme.
- Further research is warranted to explore the clinical application of these peptides in brain tumor treatment.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
